Pfizer's new trial vaccine for RSV is over 85% effective in older adults
Pfizer announced on Thursday that a vaccine designed to stop respiratory syncytial virus, or RSV, infections is over 85% effective in older adults.
Bavarian Nordic promises to increase monkeypox vaccine production as supply shrinks
The producer of the only approved monkeypox vaccine is promising to increase the production of vaccine doses as supply falters and cases increase.
Health care workers fired over vaccine mandate awarded $10 million in settlement
Illinois health care workers who filed a lawsuit against their employers' vaccine mandate were awarded a $10 million settlement after arguing the rule violated Title VII.
Pfizer CEO Albert Bourla says he tested positive for COVID-19, has mild symptoms
Pfizer Chairman and CEO Albert Bourla said he was isolating and taking a course of Paxlovid after testing positive for COVID-19 and experiencing mild symptoms.
Carnival Cruises drops exemption request for unvaccinated guests, eases testing requirements
Carnival Cruise Line is simplifying its testing and vaccination protocol for its guests on its fleet of ships on all cruises under 16 nights. Vaccinated passengers won't test.
Novavax tumbles 31% as waning COVID-19 vaccine demand hits revenue forecast
Novavax fell 31% Tuesday amid falling demand for the COVID-19 shot from low and middle-income nations, which caused the company to cut its annual expectations in half.
Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial
On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.
Forecasted sales for Moderna COVID vaccine remain unchanged despite COVAX program cutting orders
Moderna COVID vaccine sales forecast remains unchanged, even as the COVAXvaccine sharing program cuts orders. Moderna plans on having their BA.4 and BA.5 boosters ready by fall.
Newly approved monkeypox vaccine by Japan's KM Biologics sees immediate overseas demand
A new monkeypox vaccine, manufactured by KM Biologics Co, a Japanese pharmaceutical company, is garnering overseas interest as the disease spreads around the globe.
Dr. Nesheiwat on Biden testing positive for COVID-19
Fox News contributor Dr. Janette Nesheiwat weighs in on calls for mask mandates to return throughout America and the effectiveness of COVID-19 vaccines on 'Cavuto: Coast to Coast.'
FDA authorizes Novavax COVID-19 vaccine for emergency use
Novavax's COVID-19 vaccine was granted emergency use authorization by the FDA on Wednesday, setting it up to be a fourth vaccine option for Americans.
Medical expert weighs in on new COVID variant 'Ninja'
Internal Medicine expert and InfuseChi Dr. Adalbert Pilip breaks down why the new COVID variant, 'Ninja,' may be more likely to cause breakthrough cases on 'The Evening Edit.'
Curevac sues BioNTech over COVID-19 vaccine's mRNA technology
CureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.
Oxford Biomedica signs new deal to make AstraZeneca COVID shot
Britain's Oxford Biomedica announced an agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022. It has already manufactured more than 100 million doses since 2020.
BioNTech, Pfizer to start testing universal vaccine for coronaviruses
BioNTech, Pfizer's Germany-based partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation coronavirus vaccines.
US FDA will decide on redesigned COVID vaccines by early July
The FDA will decide on whether changes are needed to the COVID vaccines in order to keep up with recent coronavirus variant by early July.
Publix not giving COVID-19 vaccine to children younger than 5
Publix will not be offering COVID-19 vaccines to children younger than 5, a spokesperson for the supermarket chain told Fox 13 Tampa Bay on Wednesday.
U.S. begins rolling out COVID vaccines for young children
According to the White House's COVID-19 response coordinator Dr. Ashish Jha, the U.S has begun distributing COVID-19 vaccines for children as young as six months.
Pfizer agrees to invest more than $95M to buy stake in French vaccines company Valneva
Pfizer agreed to invest $95.24 million to buy an 8% percent stake in French vaccine company Valneva as the two companies work to stop Lyme disease.
FDA panel recommends Pfizer and Moderna COVID-19 vaccines for children as young as 6 months old
Pfizer and Moderna's vaccines for children as young as 6 months old could be available next week after an FDA advisory panel recommended them on Wednesday.